Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
35,991,250
-
Number of holders
-
7
-
Total 13F shares, excl. options
-
104,357
-
Shares change
-
-53,591
-
Total reported value, excl. options
-
$506,000
-
Value change
-
-$319,219
-
Number of buys
-
4
-
Number of sells
-
-5
-
Price
-
$4.86
Significant Holders of RenovoRx, Inc. - Common Stock (RNXT) as of Q4 2021
10 filings reported holding RNXT - RenovoRx, Inc. - Common Stock as of Q4 2021.
RenovoRx, Inc. - Common Stock (RNXT) has 7 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 104,357 shares
of 35,991,250 outstanding shares and own 0.29% of the company stock.
Largest 10 shareholders include Board of Trustees of The Leland Stanford Junior University (60,863 shares), Cambridge Investment Research Advisors, Inc. (14,400 shares), Virtu Financial LLC (13,208 shares), Verition Fund Management LLC (10,283 shares), UBS Group AG (4,512 shares), Tower Research Capital LLC (TRC) (891 shares), Carmichael Hill & Associates, Inc. (200 shares), CITADEL ADVISORS LLC (0 shares), Schonfeld Strategic Advisors LLC (0 shares), and TWO SIGMA SECURITIES, LLC (0 shares).
This table shows the top 7 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.